Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
This research was supported by the National Natural Science Foundation of China (82505462)
Children and adolescents lack safety data for this population
Research Disclaimer: Doses reported below are from published preclinical research protocols
Increasing focus on developing biologics such as monoclonal antibodies (mAbs) for therapeutic purposes The demand for monoclonal antibody therapies is increasing rapidly owing to their high specificity and ability to treat various chronic and life-threatening diseases
Lillig et al., 2005)
In the SURMOUNT-1 trial, 24-26% of participants experienced nausea at some point during the study, most commonly during dose escalation phases
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
